Novel repressor of the human FMR1 gene - identification of p56 human (GCC)(n)-binding protein as a Krüppel-like transcription factor ZF5.

Department of Biochemistry, Institute of Experimental Medicine, Russian Academy of Medical Sciences, St Petersburg, Russia.
FEBS Journal (Impact Factor: 4.25). 10/2007; 274(18):4848-62. DOI: 10.1111/j.1742-4658.2007.06006.x
Source: PubMed

ABSTRACT A series of relatively short (GCC)(n) triplet repeats (n = 3-30) located within regulatory regions of many mammalian genes may be considered as putative cis-acting transcriptional elements (GCC-elements). Fragile X-mental retardation syndrome is caused by an expansion of (GCC)(n) triplet repeats within the 5'-untranslated region of the human fragile X-mental retardation 1 (FMR1) gene. The present study aimed to characterize a novel human (GCC)(n)-binding protein and investigate its possible role in the regulation of the FMR1 gene. A novel human (GCC)(n)-binding protein, p56, was isolated and identified as a Krüppel-like transcription factor, ZF5, by MALDI-TOF analysis. The capacity of ZF5 to specifically interact with (GCC)(n) triplet repeats was confirmed by the electrophoretic mobility shift assay with purified recombinant ZF5 protein. In cotransfection experiments, ZF5 overexpression repressed activity of the GCC-element containing mouse ribosomal protein L32 gene promoter. Moreover, RNA interference assay results showed that endogenous ZF5 acts as a repressor of the human FMR1 gene. Thus, these data identify a new class of ZF5 targets, a subset of genes containing GCC-elements in their regulatory regions, and raise the question of whether transcription factor ZF5 is implicated in the pathogenesis of fragile X syndrome.

  • [Show abstract] [Hide abstract]
    ABSTRACT: While FMR1 is silenced in Fragile X syndrome (FXS) patients carrying the full mutation, its expression is elevated (2-8 fold) in premutated individuals. These people may develop the Fragile X-associated Tremor/Ataxia syndrome (FXTAS), a late onset neurodegenerative disorder characterized by ataxia and parkinsonism. In addition, people carrying the premutation can be affected by a set of neurological and behavioural disorders during young age. Problems of memory have been detected in these patients as well as in the mouse models for FXTAS. To date little is known concerning the metabolism of FMR1 mRNA, notwithstanding the importance of the finely tuned regulation of the expression of this gene. In the present study we identified three microRNAs that specifically target the 3'UTR of FMR1 and can modulate its expression throughout the brain particularly at the synapse where their expression is very high. The expression level of miR-221 is reduced in synaptosomal preparations of young FXTAS mice suggesting a general deregulation of transcripts located at the synapse of these mice. By transcriptome analysis we show here a robust deregulation of the expression levels of genes involved in learning, memory and autistic behavior, Parkinson disease and neurodegeneration. These findings suggest the presence of a 'synapthopathy' in these animals. Interestingly, many of those deregulated mRNAs are target of the same miRNAs that modulate the expression of FMR1 at the synapse.
    Human Molecular Genetics 02/2013; · 7.69 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Complement C3 is involved in various protective and regulatory mechanisms of immune system. Recently it was established that C3 expression is regulated by nuclear receptors. Hepatic nuclear factor 4α (HNF4α) is a nuclear receptor critical for hepatic development and metabolism. We have shown that HNF4α is a positive regulator of C3 gene expression, realizing its effects through binding to two HNF4-response elements within the C3 promoter in HepG2 cells. TNFα is a well established positive regulator of C3 expression in hepatocytes during acute phase of inflammation. TNFα decreases the amount of HNF4α protein in HepG2 cells through NF-κB and MEK1/2 pathways thereby leading to decrease in HNF4α bound to the C3 promoter. TNFα and HNF4α act in a synergetic way resulting in the potent activation of C3 transcription. These results suggest a novel mechanism of C3 regulation during acute phase response in HepG2 cells and display the mechanism of interaction of TNFα-induced pathways and HNF4α in transcriptional regulation of C3 gene.
    Gene 04/2013; · 2.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The human FMR1 gene encodes an RNA-binding protein taking part in translation regulation. The 5′-untranslated region of FMR1 gene contains a large number of tandem repeats of GCC triplets (5–50); an increase in their number by more then 200 times is responsible for fragile X syndrome (human congenital anomaly). At least two transcription factors are thought to be able to interact specifically with triplet repeats (GCC)n, i.e., CGGBP-20 and ZF5 in regulatory regions of some genes. In this work, roles of these factors in the regulation of FMR1 gene expression was studied. Using the method of gel retardation, the selective binding of recombinant protein ZF5 with the sequence (GCC)9 has been shown. The tissue-specific distribution of protein ZF5 in mammalian cells overlaps with the known expression regions of the FMR1. By using specific interfering RNA (RNA-i ZF5), it has been shown that the suppression of activity for the expression of the ZF5 gene in cells of the human HepG2 hepatoma stimulates at least 1.5 times the expression of the endogenous FMR1 gene in these cells, which indicates the negative character of the regulation of the expression of the FMR1 gene by the ZF5 transcription factor. In addition GCC repeats, the 5′ regulatory region FMR1 contains classic (canonical) sites of ZF5 binding located near the points of initiation of transcription. Two genetic constructions have been created to elucidate the contribution of the GCC triplet repeats to FMR1 gene regulation by transcription factors ZF5 and CGGBP-20; these constructions contain the reporter gene of luciferase under the control of the cloned deletional variant of the 5′ regulatory region of the human FMR1 gene and differ by the presence of (GCC)9 triplet repeats in this region. In experiments on the cotransfection of the human HepG2 hepatoma cells by these genetic constructions, together with vectors of expression of the ZF5 and/or CGGBP-20 genes, ZF5 has been established to suppress the activity of the 5′ regulatory FMR1 region through classic sites of binding. Moreover, the presence of GCC repeats attenuates the inhibitory ZF5 effect on the activity of the 5′ regulatory FMR1 region. CGGBP-20 suppresses activity of the 5′ regulatory FMR1 region only in the presence of GCC triplet repeats. The obtained data indicate the differently directed action of the transcription factor ZF5 on the FMR1 gene, which can explain the previously shown increase in the level of FMR1 mRNA in carriers of premutant alleles. Key words: GCC triplet repeats, fragile X syndrome, human FMR1 gene expression regulation, ZF5 and CGGBP-20 transcription factors. Key wordsGCC triplet repeats-fragile X syndrome-human FMR1 gene expression regulation-ZF5 and CGGBP-20 transcription factors
    Cell and Tissue Biology 01/2009; 4(1):54-62.

Full-text (2 Sources)

Available from
Jun 3, 2014